Papaverine
2023-03-26:
Papaverine #
Selective PDE10A inhibitor. TAK-063 is also one
- Long-term D2 antagonism would increase supersensitivity, but PDE10Ais prevents this.
- Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating
-
Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice
- Machine: This flawed study could be infact due to papaverine off target effects. I think it hits noiciceptin receptor or something. It is in fact procognitive:
- Balanced Activation of Striatal Output Pathways by Faster Off-Rate PDE10A Inhibitors Elicits Not Only Antipsychotic-Like Effects But Also Procognitive Effects in Rodents
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington’s disease mouse model
- Machine: This flawed study could be infact due to papaverine off target effects. I think it hits noiciceptin receptor or something. It is in fact procognitive:
- Neurogenic component in the effect of papaverine, drotaverine and bencyclane
- Inhibited conditioned avoidance behavior
Dose #
Actually sold on bgpharm: https://www.bgpharmadrugs.com/product/papaverine-sopharma-20-mg-ml-solution-for-injection-10-ampules/